Berikutnya

Putar otomatis

Advanced or Recurrent Endometrial Cancer Clinical Trial

0 Tampilan • 07/09/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

The purpose of this clinical trial is to study the good and bad effects of adding the PD-1 inhibitor called pembrolizumab to standard treatment for advanced or recurrent endometrial cancer. http://www.bigtencrc.org

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis